2cureX AB today announces the signing of a strategic services and collaboration agreement with StoreMyTumor, a US-based oncology logistics and tumour preservation platform operating under AAA Health Solutions.
The agreement supports the continued expansion of 2cureX AB’s broader Functional Precision Medicine infrastructure, including patient access pathways, tumour collection coordination, cryopreservation logistics, and future integration opportunities across decentralised oncology testing workflows.
The collaboration is intended to strengthen operational connectivity between patients, clinics, laboratories, and future testing platforms, supporting the company’s broader ecosystem strategy within precision oncology.
StoreMyTumor’s tumour preservation and logistics capabilities may also support future applications connected to 2cureX AB’s developing TwinCode strategy and broader data-driven oncology initiatives.
“This collaboration represents another important step in the continued development of our broader Functional Precision Medicine infrastructure,” said Nat Hutley, CEO of 2cureX AB. “We believe the future of precision oncology will increasingly depend on operational coordination, patient access, and scalable ecosystem partnerships alongside testing technologies themselves.”
The agreement is expected to support future commercial and operational opportunities within both European and US precision oncology markets.